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 ABSTRACT 
 
Innovations in methods and technologies are equipping researchers with unprecedented 
capabilities for detecting and characterizing pathologic processes in the developing human 
brain.  As a result, there is growing enthusiasm about the prospect of achieving clinically useful 
tools that can assist in the diagnosis and management of mental health and learning disorders. 
For these ambitions to be realized, it is critical to accrue large-scale multimodal datasets that 
capture a broad range of commonly encountered clinical psychopathology. To this end, the 
Child Mind Institute has launched the Healthy Brain Network (HBN), an ongoing initiative 
focused on creating and sharing a biobank comprised of data from 10,000 New York City area 
children and adolescents (ages 5-21). The HBN has adopted a community-referred recruitment 
model. Specifically, study advertisements seek the participation of families who have concerns 
about one or more psychiatric symptoms in their child. The HBN Biobank houses data about 
psychiatric, behavioral, cognitive, and lifestyle (e.g., fitness, diet) phenotypes, as well as 
multimodal brain imaging, electroencephalography, digital voice and video recordings, genetics, 
and actigraphy. In this paper, we present the motivation, rationale and design for the HBN along 
with the initial implementation and evolution of the HBN protocols. We describe the first major 
open data release (n = 664) containing descriptive, electroencephalography, and multimodal 
brain imaging data (resting state and naturalistic viewing functional MRI, diffusion MRI and 
morphometric MRI). Beyond accelerating transdiagnostic research, we discuss the potential of 
the HBN Biobank to advance related areas, such as biophysical modeling, voice and speech 
analysis, natural viewing fMRI and EEG, and methods optimization.  
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1. PURPOSE OF DATA COLLECTION  
Psychiatric and learning disorders are among the most common and debilitating illnesses 
across the lifespan. Epidemiologic studies indicate that 75% of all diagnosable psychiatric 
disorders begin prior to age 24 ​1​.  This underscores the need for increased focus on studies of 
the developing brain ​2​. Beyond improving our understanding of the pathophysiology that 
underlies the emergence of psychiatric illness throughout development, such research has the 
potential to identify clinically useful markers of illness that can improve the early detection of 
pathology and guide interventions. Although the use of neuroimaging, neuropsychology, 
neurophysiology and genetics has made significant strides in revealing biological correlates for 
a broad array of illnesses, findings have been lacking in specificity​3​. Consequently, progress in 
finding clinically useful brain-based biomarkers has been disappointing ​4,5​.  
 
Given the slow pace in biomarker identification, investigators have been prompted to rethink 
research paradigms and practices. Most notably, the emphasis on mapping diagnostic labels 
from a clinically defined nosology (e.g., the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) or the International Classification of Diseases) to varying biological indices has 
proven to be problematic, as it assumes consistent biological relationships with broad 
constellations of signs and symptom ​6,7​. Epidemiologists, psychopathologists, geneticists and 
neuroscientists are reconsidering the relevance of diagnostic boundaries due to the lack of 
specificity in related findings. Two psychiatric research approaches have emerged. First is the 
adoption of transdiagnostic models organized around behavioral and neurobiological 
dimensions that transcend existing diagnostic boundaries​3​. Second is the use of diagnostic 
subtyping to explain variation within diagnostic categories through the detection of behaviorally 
or biologically homogeneous subgroups​8–10​. These two strategies of parsing psychiatric illness 
are not mutually exclusive, and can inform each other.  
 
Transdiagnostic and subtyping strategies call for changing the designs of future studies away 
from those typically applied to clinical neuroscience research ​4​. First, we must move away from 
studying disorders in isolation from one another and from relying on ​“extreme comparisons”​ in 
which clinical samples are compared to healthy controls (often “super healthy” controls), rather 
than offering comparisons with individuals experiencing other clinical conditions. Unless this 
happens, the clinical relevance of published findings will remain limited, because they will 
provide little insight into real-world challenges of differentiating forms of psychopathology (i.e., a 
psychiatrist can easily differentiate an individual with schizophrenia from a healthy control but 
may find it much more challenging to determine whether psychosis or a mood disorder is the 
primary problem). Second, our science has been ravaged by its reliance on small sample sizes 
that are vastly underpowered given the high dimensionality and usual small effect sizes of 
biological phenomena.  This applies to imaging, genetics, or physiologically-based measures. 
Third, sample ascertainment can no longer be dependent on clinics, as the resulting samples 
bring with them a wide-range of multifaceted biases, including but not limited to symptom 
severity, sex distribution and problems related to access to care. As a result, there is a pressing 
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need for community-based and epidemiologic samples​11​. Clearly, the time has come for 
changes in methods at all levels of our science. 
 
In response to these challenges, and the scarcity of transdiagnostic datasets available for 
neuroscientific studies in children and adolescents, the Child Mind Institute has launched the 
Healthy Brain Network (HBN) initiative. As part of this initiative, the HBN is creating a Biobank 
from a community sample of 10,000 children and adolescents (ages 5-21) residing in the New 
York City area. The HBN Biobank includes behavioral and cognitive phenotyping, as well as 
multimodal brain imaging, electroencephalography (EEG), genetics, digital voice and video 
samples, and actigraphy. The HBN Biobank has an extensive phenotyping protocol that 
includes comprehensive psychiatric and learning assessments, as well as instruments probing a 
range of familial, environmental and lifestyle variables (e.g., physical activity, nutrition). 
Consistent with the model established by the NKI-Rockland Sample ​12​, all data obtained are 
being shared on a pre-publication basis throughout the six-year course of the data acquisition 
phases for the project. Taken together, access to such a range of data  will ensure that the HBN 
Biobank will allow for scholars to address rich and clinically relevant questions. 
 
What follows is an overview of the project plan and protocol details for the HBN Biobank; we 
also describe strategies and tests developed as part of the process of ensuring that the HBN 
initiative can be scaled up to meet its high throughput goals. Finally, we provide descriptions 
and quality assurance characteristics for the initial major data release (n=664). 
 
2. METHODS 
2.1 Recruitment Strategy. 
A primary goal for the HBN is to generate a dataset that captures the broad range of 
heterogeneity and impairment that exists in developmental psychopathology. Accordingly, we 
adopted a community-referred recruitment model. We used advertisements to encourage 
participation of families who have concerns about psychiatric symptoms in their child.  The 
“announcements” were distributed to community members, educators and local care providers, 
as well as directly to parents via email lists and events. The advertisements highlight the 
potential value of participation for children who may require school-based accommodations. In 
particular, the comprehensive diagnostic evaluation reports provided by HBN include clinical 
impressions and actionable treatment recommendations; when appropriate, the reports can be 
used to acquire an Individualized Education Program (IEP) - a prerequisite for obtaining school 
accommodations and services, as well as specialized classroom placements. Up to three 
feedback sessions and referral information are provided to participants and their families as 
well. Modest monetary compensation for their time and expenses incurred are also provided. 
 
It is important to note that our recruitment strategy was developed to achieve the major goals of 
the HBN after considering the alternative of a fully representative epidemiologic design. The 
primary HBN goal is to generate a large-scale, transdiagnostic sample for biomarker discovery 
and for investigations of the neural substrates associated with commonly occurring illness 
phenotypes. While HBN ascertainment is not clinic-based, per se, the strategy of recruiting on 
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the basis of perceived clinical concern dictates that the HBN sample will include a high 
proportion of individuals affected by psychiatric illness. Nonetheless, despite the lack of rigorous 
epidemiologic ascertainment, the intended scale of data collection and the inclusion of 
inherently diverse communities across NYC may approximate representativeness for the 
sample.  The scale of the sample should also allow investigators to study selected sub-cohorts 
of interest for targeted study (e.g., comparing individuals with ADHD residing in Midtown 
Manhattan vs. those residing in Staten Island). Finally, depending on the ability to secure 
financial support, the fourth phase of HBN will switch strategies to make the final 1500 
participants a representative epidemiologic cohort. 
 
2.2 Participant Procedures.  
 
2.2.1 Screening.  
To determine eligibility and ensure safety, potential participants or their legal guardians (if they 
are under age 18) complete a prescreening phone interview with an intake coordinator. This 
screening interview obtains information regarding an individual’s psychiatric and medical history. 
With few exceptions, the presence of psychiatric, medical, or neurological illness do not exclude 
participation. Primary causes for exclusion center on the presence of acute safety concerns 
(e.g., danger to self or others), cognitive or behavioral impairments that could interfere with 
participation (e.g., being nonverbal, IQ less than 66) or medical concerns that are expected to 
confound brain-related findings (see Table 1). All individuals meeting inclusion criteria, without 
any reasons for exclusion, are invited to participate in the study. 
 
2.2.2 Medication.  
Participants taking stimulant medication are asked to discontinue their medication during the 
days of participation, as stimulants are known to have an effect on cognitive and behavioral 
testing, as well as functional brain mapping. Participants who choose not to discontinue 
medication, or whose physicians require that medication not be interrupted, are still enrolled. 
Medication taken on the day of participation is recorded. 
 
2.2.3 IRB Approval.  
The study was approved by the Chesapeake Institutional Review Board 
(https://www.chesapeakeirb.com/). Prior to conducting the research, written informed consent is 
obtained from participants ages 18 or older. For participants younger than 18, written consent is 
obtained from their legal guardians and written assent obtained from the participant. 
 
2.3 Project Plan.​ The HBN has a four-phase project plan (see Table 2). The goals for each of 
the phases are as follows: 
  
Phase I: Implementation and Testing (Participants 1-500; completed).​ The overarching goal of 
the initial phase was to establish a prototype HBN Diagnostic Research Center, located in 
Staten Island, New York (one of the five boroughs of New York City). Prototype development 
was intended to establish all project workflows and strategies/procedures for recruitment, 
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diagnostic evaluations, phenotypic assessments, and a referral network (i.e., health care 
providers to whom participants can be referred if clinical significant concerns are detected). The 
initial protocol included diagnostic evaluations, phenotypic assessments, EEG and magnetic 
resonance imaging (MRI). During the initial phase, we also evaluated the feasibility and benefits 
of using a mobile MRI scanner, as well as a mobile Diagnostic Research Center.  
  
Phase II: Revision and Hardening (Participants 501-1000; completed).​ A key challenge for 
almost any large-scale study is balancing the desire to maintain stable protocols and 
assessments across the entirety of a sample with the desire to integrate new measures and 
make changes based on learning from experiences and scientific advances along the way. 
Phase II of the Healthy Brain Network had two primary goals: 1) the addition and/or deletion of 
protocols established during Phase I, based on lessons learned and new developments; and, 2) 
hardening the revised protocols to ensure that they are as optimal and robust as possible, while 
also reflecting the current state of the art in science and practice.  
  
Phase III: Scale-up (Participants 1001-8500; in process).​ ​Building on the experience and 
lessons learned from Phases I and II of the project, the Healthy Brain Network has started 
Phase III, with the goal of enrolling 7,500 participants in our established protocol. This goal 
necessitates increased capacity for both recruitment and enrollment. As such, Phase III includes 
additional Diagnostic Research Centers and MRI scan sites in the New York City region; sites 
are being chosen to increase the diversity of populations that can be reached. 
 
Phase IV: Targeted Recruitment (Participants 8501-10000).​ ​The final phase of the Healthy Brain 
Network will incorporate epidemiologic sampling to recruit an additional targeted representative 
sample of 1,500 participants.  
 
2.4 Experimental Design. 
The HBN protocol spans four sessions, each approximately three hours in duration (see Table 
3). A list of all measures collected during the assessment can be found in Table 4. The 
assessment includes: 
  
2.4.1 Clinician-Administered Assessments  
The clinical staff consists of a combination of psychologists and social workers, with 
psychopharmacological consultation support provided by psychiatrists. All the tests in this 
section are administered by, or directly under the supervision of, licensed clinicians. Participant 
responses are first scored by the administering clinician. To enhance validity, the entire set of 
responses is again scored by a trained research assistant. Finally, all test scores from clinical 
interviews are double-entered into the database by two (different) trained research assistants. 
  
Semi-Structured Diagnostic Interview.​ ​All participants are administered the Schedule for 
Affective Disorders and Schizophrenia - Children’s version (KSADS)​13​. The KSADS is a 
semi-structured DSM-5-based psychiatric interview used to derive clinical diagnoses; 
administration in the HBN is performed by a licensed clinician. The KSADS includes a 
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clinician-conducted parent interview and child interview, which result in automated diagnoses. 
Following completion of the interviews and review of all materials collected during study 
participation, clinically synthesized diagnoses (i.e., consensus DSM-5 diagnoses) are generated 
by the clinical team. The HBN data include the KSADS interview data along with the 
algorithm-generated diagnoses, as well as consensus clinical diagnoses, for each participant. 
 
Additional Diagnostic Assessments.​ ​For a subset of psychiatric disorders, specific follow-up 
assessments are completed, as indicated for additional clinical characterization beyond the 
KSADS (e.g., Autism Diagnostic Observation Schedule [ADOS]​14​ for suspected autism, Clinical 
Evaluation of Language Fundamentals [CELF]​15​ for suspected language disorder) (See Table 
5). These targeted supplemental diagnostic assessments are not administered to individuals 
without a suspicion of the presence of clinically significant illness in the corresponding domain. 
 
Intelligence and Learning.​ ​Participants ages 6-17 complete the Wechsler Intelligence Scale for 
Children (WISC-V)​16​. Participants age 5, and those believed to have an IQ below 70, complete 
the Kaufman Brief Intelligence Test (KBIT)​17​. Participants ages 18 and older complete the 
Wechsler Adult Intelligence Scale (WAIS-IV)​18​. All participants ages 6 and older complete the 
Wechsler Individual Achievement Test (WIAT III)​19​. 
  
Language.​ ​Trained research assistants and clinicians administer language screening tests as 
indicated, including the Clinical Evaluation of Language Fundamentals (CELF-5) Screener, the 
Goldman Fristoe Test of Articulation (GFTA) ‘Sounds and Words’ subtest​20​, the Comprehensive 
Test of Phonological Processing, Second Edition (CTOPP-2)​21​, and the Test of Word Reading 
Efficiency, Second Edition (TOWRE-2)​22​. In addition, participants who fail the CELF-5 Screener 
and/or perform poorly on GFTA subtests are offered additional language evaluations performed 
by a licensed speech and language pathologist. This assessment includes the full CELF-5 
assessment, Expressive Vocabulary Test (EVT)​23​, the Peabody Picture Vocabulary Test 
(PPVT)​24​, and additional subtests of the GFTA. 
  
2.4.2 Self-Administered Assessments  
Participant report and parent measures are acquired via the online patient portal of the NextGen 
electronic medical record system. Direct electronic entry of responses by participants minimizes 
the burden on research staff and removes the potential for errors that arise when questionnaires 
are administered using pen and paper, and then manually entered into a database. Structured 
questionnaires assess behavior, family structure, stress and trauma, as well as substance use 
and addiction (see Table 4). Each participant completes a set of questionnaires specific for 
his/her age and according to the protocol version at time of participation. See Figure 1 for a 
timeline of changes to the HBN assessment protocol over the first two years of the project.  
 
In the case of teacher reports, paper forms are used to collect data (e.g., Teacher Report 
Forms​25​) due to varying levels of receptiveness for electronic forms. All data collected on paper 
are double-entered by trained research assistants. 
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2.4.3 Computerized Testing  
Given the emphasis on clinically and educationally relevant assessments, limited time was 
available for additional computerized testing. To facilitate overlaps with cognitive phenotyping in 
other efforts, a subset of the NIH Toolbox has been included, consisting of: Flanker Task 
(Executive Function/Inhibitory Control and Attention), Card Sort (Executive 
Function/Dimensional Change), and Pattern Comparison (Processing Speed)​26​. In June 2017, 
an additional 1-minute task measuring temporal discounting was added to the HBN protocol ​27​. 
  
2.4.4 Fitness Testing 
Basic physical measurements (e.g., height, weight, and waist circumference) and cardiovascular 
measures (e.g., blood pressure and heart rate) are collected by trained research assistants. 
Cardiovascular fitness is assessed using a modified version of the FitnessGram test battery. 
FitnessGram​28​ is a widely used health-related physical fitness assessment that measures five 
different parameters, including aerobic capacity, muscular strength, muscular endurance, 
flexibility, and body composition. A treadmill test is used to measure maximal oxygen 
consumption for the purposes of estimating VO​2​max. Bioelectric impedance measures, used for 
the calculation of various indices of body composition (e.g., body mass index,percent body fat, 
percent water weight), are taken using the RJL Systems Quantum III BIA system.  
 
2.4.5 Electroencephalography (EEG) and Eye Tracking.  
For each participant, EEG and eye-tracking data are obtained during a battery that was 
previously assembled to examine attention, perception, inhibitory control, and 
decision-making ​29​. See Table 6 for the specific paradigms and brief descriptions of each.  
High Density EEG. ​High-density EEG data are recorded in a sound-shielded room at a sampling               
rate of 500 Hz with a bandpass of 0.1 to 100 Hz, using a 128-channel EEG geodesic hydrocel                
system by Electrical Geodesics Inc. (EGI). The recording reference is at Cz (vertex of the head).                
For each participant, head circumference is measured and an appropriately sized EEG net is              
selected. The impedance of each electrode is checked prior to recording to ensure good              
contact, and is kept below 40 kOhm. Time to prepare the EEG net is no more than 30 min.                 
Impedance is tested every 30 min of recording and saline added if needed. 
Eye tracking. ​During EEG recordings, eye position and pupil dilation are also recorded with an               
infrared video-based eye tracker (iView-X Red-m, SensoMotoric Instruments [SMI] GmbH) at a            
sampling rate of 120 Hz. This system has a spatial resolution of 0.1° and a gaze position                
accuracy of 0.5°. The eye tracker is calibrated with a 5-point grid before each paradigm.               
Specifically, participants are asked to direct their gaze in turn to a dot presented at each of 5                  
locations (center and four corners of the display) in a random order. In a validation step, the                 
calibration is repeated until the error between two measurements at any point is less than 2°, or                 
the average error for all points is less than 1°. 
 
2.4.6 Magnetic Resonance Imaging (MRI). 
Test Phase (mobile 1.5T ​Siemens Avanto ​). ​Imaging data were collected using a 1.5T Siemens 
Avanto system equipped with 45 mT/m gradients in a mobile trailer ​(Medical Coaches, Oneonta, 
NY). The scanner was selected to pilot the feasibility of using a mobile MRI platform to achieve 
a single scanner solution for the challenges of scanning at geographically distinct locations in 
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the NY area. To maximize long term stability, the trailer was parked on 10-inch thick concrete 
pads. The system was upgraded with 32 RF receive channels, the Siemens 32-channel head 
coil, and the University of Minnesota Center for Magnetic Resonance Research (CMRR) 
simultaneous multi-slice echo planar imaging sequence ​30​. Scanning included resting state fMRI, 
diffusion kurtosis imaging (DKI) structural MRI (T1, T2-space), Magnetization Transfer Imaging, 
quantitative T1 and T2 mapping (DESPOT T1/T2 ​31​) and imaging of visceral fat (T1W). See 
Table 7 for the full scan protocol and Table 8 for parameters. 
Deployment Phase I (3.0T Siemens Tim Trio). ​Imaging data were collected using a Siemens 3T 
Tim Trio MRI scanner located at the Rutgers University Brain Imaging Center (RUBIC). The 
scanner was selected based on physical proximity to the HBN Diagnostic Research Center in 
Staten Island, New York (12.7 miles; average ride duration: 24 minutes). The system is 
equipped with a Siemens 32-channel head coil and the CMRR simultaneous multi-slice echo 
planar imaging sequence. When possible, the structural and functional MRI scan parameters 
were selected to facilitate harmonization with the recently launched NIH ABCD Study (this was 
not possible for the diffusion imaging due to limitations of the Trio platform). See Table 7 for 
scan protocol layout and Table 8 for parameters. Of note, two naturalistic viewing fMRI scans 
were added to the protocol (“Despicable Me” [10 minute clip; added October 28, 2016], “The 
Present” [~4 minutes; added November 23, 2016]). 
Deployment Phase II (3T Siemens Prisma).​ In late 2017, Phase II scanning will begin using 
Prisma scanners located at the CitiGroup Cornell Brain Imaging Center and the CUNY 
Advanced Science Research Center. The imaging sequence protocols will be harmonized to the 
NIH ABCD Study​. 
 
2.4.7 Voice and Video Recording and Actigraphy Data Collection. 
Behavior monitoring technologies have the potential to help infer internal states of participants 
during assessments​32​. ​Voice analysis stands out as particularly promising, given its increasing 
application in psychiatry (e.g., to assess mood and anxiety​33​), in neurology (e.g., to assess 
motor function in populations such as those affected by Parkinson’s disease ​34​) and in 
developmental studies (e.g., to assess pubertal stage ​35​). The ease with which one can record 
audio samples in a controlled setting is particularly appealing. Among sensor-based wearable 
devices, accelerometer-based actigraphy is a promising means ​of monitoring behavior related 
to movement and sleep ​36​. ​For participants in Phase III, the collection of audio and video 
recordings have begun; actigraphy data collection will  be implemented in July 2017.  
Voice recording.​ ​During the administration of all assessments and interviews, starting with 
subject 746, audio recordings are being collected using a portable Sony ICD-UX 533 digital 
voice recorder. Additionally, while in the MRI scanner, participants view an animated 
emotionally evocative four-minute film, titled “The Present”; immediately after coming out of the 
scanner, participants are prompted to narrate the story in their own words and answer a series 
of perspective-taking questions that are related to the film content. During this narration and 
question answering session, high-fidelity audio recordings are collected with a ​Rode ​ NT1 
cardioid condenser microphone. Additionally, high-definition video of their face and upper body 
is collected simultaneously with a Canon XC15 digital camcorder. The audio recordings enable 
voice and speech analysis and the video recordings are envisioned to be useful for facial 
expression analyses.  
Actigraphy. Plans are underway to provide each participant with a wrist-worn ActiGraph            
wGT3X-BT to monitor movement throughout the day and night. Participants will be requested to              
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wear the device every day for one month. The device will be recharged and its data downloaded                 
during each visit. 
 
2.4.8. Genetics. ​Since December 2016, all participants are asked to provide a saliva sample for               
genetics using the Oragene Discover (OGR-500) DNA collection kit. This collection strategy was             
put in place as an alternative to the initially planned blood collection to be carried out in the                  
diagnostic research center, which was found to create logistical challenges in the office. Starting              
in July 2017, saliva samples will be complemented by blood collected in the participant’s home               
by a local phlebotomy service that the HBN has contracted. Resulting materials will be donated               
to the NIMH Genetics Repository for sharing.  
 
2.4.9 Lessons Learned 
Over the course of the development and the implementation of Phases I and II, we have 
overcome challenges and learned a variety of lessons. Some of the key challenges and 
solutions that may benefit others are highlighted below: 
 
1.​     ​Incentivizing Participation. ​Recruitment is a key challenge for large-scale data generation 
initiatives, especially when data capture is not simply an add-on to ongoing activities (e.g., 
addition of a blood sample in clinics or a questionnaire in schools). While scientists commonly 
justify the funding of research based on potential long-term scientific benefits, the general public 
tends to evaluate the utility of research participation based on more immediate needs - 
particularly when participation demands a substantial amount of time and energy. Early in the 
development of HBN, these competing agendas were repeatedly highlighted by potential 
community partners. As a result, the HBN has attempted to maximize the quality and breadth of 
feedback and recommendations that are provided to families and caregivers; the information 
provided is derived from clinically relevant data obtained over the course of participation (e.g., 
feedback report and sessions provided by licensed clinicians, generation of a referral grid for the 
NYC area). From this project’s inception, there has been emphasis on the distinction between 
the data obtained purely for research purposes (e.g., EEG, MRI) and the data that may directly 
benefit participants. This distinction has helped to manage expectations and answer 
participants’ and family members’ questions about the scope and utility of the project. 
2.     Balancing Experimental Needs and Participant Burden. ​Drawing from prior experiences 
with the NKI-Rockland Sample initiative, the HBN was initially designed to be completed in two 
6-hour days. Over the course of Phase I, we learned that many participants and their families 
preferred an alternative schedule that is better aligned with school and work schedules. As a 
result, the HBN adopted the current schedule of four 3- to 3.5-hour sessions. Despite initial 
concerns that this would lead to an increased incomplete participation rate, the current schedule 
has facilitated participation and dropout rate has remained low at around 6%.   
3.     Broadening the Scope of Phenotyping for the Study of Mental Health. ​There is a need to 
consider broader domains of impairment known to be highly associated with psychiatric illness. 
We received feedback specifically about the desirability of measuring intelligence, learning, 
 
.CC-BY-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/149369doi: bioRxiv preprint first posted online Jun. 13, 2017; 
language, speech and lifestyle considerations (e.g., fitness, eating behaviors, nutrition), so we 
replaced the abbreviated batteries commonly used for intelligence and achievement testing in 
research studies (e.g., WASI​37​, limited portions of the WIAT) with more comprehensive 
evaluations (i.e., WISC​16​, full WIAT​38​), which require an additional  90-120 minutes per 
assessment. In addition to the scientific benefits of expanding the granularity of our evaluations, 
these evaluations have sometimes been useful for obtaining individualized educational plans 
(IEPs) for students in the NYC area. Similarly, the addition of screening evaluations for speech 
and language (followed by more comprehensive evaluations when indicated) resulted in the 
identification of possible speech or language impairments in 30.6% of the children seen to date. 
4.​     ​Logistical Challenges Related to Mobile Data Acquisition. ​In part, Phase I was designed to 
assess the added value of mobile assessment vehicles for data acquisition. In particular, we 
tested the utility of an MRI scanner housed in a trailer that could be moved periodically (e.g., 
monthly), as well as a converted mobile recreational vehicle (RV) that was equipped to carry out 
all non-MRI portions of the assessment. Despite the initial substantial appeal of using these 
vehicles, logistical issues turned out to be too great. For the mobile MRI scanner, the cost of 
moving the vehicle more than once a month turned out to be substantial. Even more difficult 
was finding times to accommodate all eligible participants in the fixed available assessment 
blocks when the scanner was on-site. Potential data loss when patients are required to wait for 
the scanner to arrive was also a concern. With regard to the mobile RV for non-MRI 
assessments, the vehicle worked satisfactorily for staff and participants; however, its throughput 
was substantially less than what could be obtained in a fixed office space, where multiple 
participants can be seen simultaneously. Despite the limitations of the mobile RV for conducting 
complete evaluations, the vehicle has been a highly effective recruitment tool. Specifically, at 
community health fairs and events, the vehicle has increased knowledge about the project, and 
at such events, the vehicle has been used to provide short mental health screenings.  
5.​     ​Expanding Landscape for Biomarker Identification.​ As biomedical and mobile technologies 
and analysis methods continue to advance, the potential grows for tailored, precise, and 
accurate digital phenotyping and biomarker identification. A​ncillary data consisting of speech 
samples (audio recordings) and remote movement (actigraphy) have been recently added to the 
HBN assessment protocol. ​We are evaluating other wearable devices with sensors that track 
physiological state, such as electrodermal activity to monitor stress and photoplethysmography 
to monitor heart rate. Collection of hair samples (for determination of current metal levels) and of 
baby teeth (for determining fetal exposure to various metals​39​) are being added to the protocol. 
Microbiomics is a potentially valuable avenue of exploration that is gaining increased attention, 
but fecal and other microbiome data collection are being deferred until the practical 
considerations that such data collection entail can be worked out. 
6.​     ​Balancing Efficiency, Innovation and Tolerability of MRI Scan Protocols.​ Maximizing 
tolerability of the scanner environment and minimizing head motion are two inherent challenges 
for MRI studies, particularly those focusing on developing and clinical populations. Consistent 
with its predecessor initiative, the NKI-Rockland Sample ​12​, the HBN initially included a 
10-minute resting state scan. However, head motion was found to be problematic, particularly in 
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the second half of the scan. To address this concern, the resting state scan was eventually 
broken into two 5-minute scans at the Rutgers data collection site, and removed altogether for 5 
year olds, where data quality concerns were most notable. Additionally, for the deployment 
phase, experimental structural images (e.g., quantitative T1/T2 mapping) were removed in favor 
of increasing functional MRI scan time. Rather than adding more resting state fMRI scans, we 
opted to add naturalistic viewing (i.e., movie watching) fMRI sessions to reduce motion and to 
permit a broader range of analyses. 
7.​     ​Inclusion of Consent for Commercial Use.​ The research community increasingly aims to 
generate data and methods that will form the foundation of clinically useful tools. As the field 
attempts to market and distribute innovations, there will be a growing need for the involvement 
of commercial entities. In preparation for this next phase, we followed NIH recommendations 
and integrated a consent document for commercial use into the informed consent (starting with 
participant #527). The receipt of such permission is essential to avoid any ethical or legal 
concerns that may arise from the commercial use of data for participants who did not provided 
explicit permission.  
8.     ​Extension of Questionnaire Age Ranges. ​Initially, for each questionnaire, determination of 
whether to administer it to all participants or to a select age group was based on ages indicated 
by publisher websites, or from validation studies (e.g., ages 8-18 for the SCARED​40​). While this 
is generally sensible for self-report versions of questionnaires, particularly when reading level is 
an issue, we have called into question the value of the decision for questionnaires completed by 
parents. Although some parent-report questionnaires were only used for ages 8 and up in the 
past, or up to age 17, this does not mean they cannot be informative for the purposes of the 
HBN; lack of previously established norms (e.g., t-scores) may be overcome given the 
magnitude of the data (e.g., the SCARED). Thus, we have reviewed each questionnaire 
carefully and expanded the age ranges so that parent-report questionnaires are collected for 
participants of all ages (5-21) except where developmentally inappropriate (e.g., substance use 
questionnaires, puberty questionnaires), or where age-specific versions of the same form exist 
(e.g., ASEBA forms​25​). Increasing the age range for questionnaire administration minimizes data 
loss in the sample, particularly in the youngest and oldest participants. Additionally, collecting 
data from broader age ranges may help support extension of normative ranges. 
3. DATA RECORDS  
3.1 Data Privacy 
During the consent process, all participants provide informed consent for their data to be shared 
via IRB-approved protocols. Data sharing occurs through the 1000 Functional Connectomes 
Project and its International Neuroimaging Data-sharing Initiative (FCP/INDI)​41​. Prior to entry of 
data into the HBN Biobank, all personal identifiers specified by the Health Insurance Portability 
and Accountability Act (HIPAA) are removed, with the exception of zip code (which is only 
shared upon request following completion of the HBN Data Usage Agreement described below 
in section 3.2.1).  
 
3.2 Distribution for Use  
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3.2.1 Phenotypic Data 
Phenotypic data may be accessed through the COllaborative Informatics and Neuroimaging 
Suite (COINS) Data Exchange (​http://coins.mrn.org/dx​) or an HBN-dedicated instance of the 
Longitudinal Online Research and Imaging System (​LORIS​) located at 
http://data.healthybrainnetwork.org/​.  
 
With the exception of age, sex and handedness, which are publicly available with imaging, EEG 
and eye-tracking datasets, the HBN phenotypic data are protected by a Data Usage Agreement 
(DUA). Investigators must complete and have approved by an authorized institutional official 
before receiving access (the DUA can be found at: 
http://fcon_1000.projects.nitrc.org/indi/cmi_healthy_brain_network/sharing.html ​). Modeled after 
the  practice of the NKI-Rockland Sample, the intent of the HBN DUA is to ensure that data 
users agree to protect participant confidentiality when handling the high dimensional HBN 
phenotypic data (which includes single item responses), and that they will agree to take the 
necessary measures to prevent breaches of privacy. With the exception of zip code (which is 
only available on request), no protected health identifiers are present in data distributed through 
the DUA, as a means of ensuring minimal risk of privacy breach. The DUA does not place any 
constraints on the range of analyses that can be carried out using the shared data, nor does it 
include requirements for co-authorship by the originators of the HBN Biobank.  
 
3.2.2. EEG, Eye-tracking, and Imaging Data 
All EEG, eye tracking and imaging data can be accessed through the 1000 Functional 
Connectomes Project and its International Neuroimaging Data-sharing Initiative (FCP/INDI) 
based at ​http://fcon_1000.projects.nitrc.org/indi/cmi_healthy_brain_network​. This website 
provides an easy-to-use interface with point-and-click download of HBN datasets that have 
been previously compressed; the site also provides directions for those users who are 
interested in direct download of the data from an Amazon Simple Storage Service (S3) bucket.  
 
All data are labeled with the participant’s unique identifier. EEG data are available openly, along 
with basic phenotypic data (age, sex, handedness, completion status of EEG paradigms) and 
performance measures for the EEG paradigms. These data are located in a comma-separated 
(.csv) file accessible via the HBN website.  
 
3.3 Partial and Missing Data.  
Some participants may not be able to successfully complete all components of the HBN protocol 
due to a variety of factors (e.g., participants experiencing claustrophobia may not be able to stay 
in the scanner for the full session, a participant with sensory issues may have a more limited 
ability to participate in the EEG protocol). To prevent data loss when possible, we include 
exposure procedures such as a mock MRI scanner experience during session 1, and repeat 
exposures to an EEG cap prior to session 4. Overall, we attempt to collect as much of the data 
as possible within the allotted data collection intervals and log data losses when they occur.  
 
3.4 Data License.  
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HBN imaging, EEG and eye-tracking datasets for the first 697 participants enrolled are currently 
distributed under the Creative Commons, Attribution Non-Commercial Share Alike License 
(​https://creativecommons.org/licenses/by-nc-sa/4.0/​), as they were collected prior to the addition 
of consent for commercial use to the informed consent (specific participant IDs are specified on 
the HBN data-sharing website). From December 6, 2016 forward, HBN datasets are being 
distributed using the Creative Commons BY 4.0 License 
(​https://creativecommons.org/licenses/by/4.0/​), which does allow for commercial use of 
datasets. For the high-dimensional phenotypic data, all terms specified by the DUA must be 
complied with. 
     
4. TECHNICAL VALIDATION  
4.1 Quality Assessment  
Consistent with policies established through our prior data generation and sharing initiatives 
(i.e., FCP/INDI​41​; NKI-Rockland Sample ​12​), all imaging datasets collected through the HBN are 
being made available to users, regardless of data quality. This decision is justified by a lack of 
consensus in the imaging community on what constitutes “good” or “poor” quality data. Also, 
“lower quality” datasets can facilitate the development of artifact correction techniques and of 
evaluating the impact of such real-world confounds on reliability and reproducibility. Given the 
range of clinical presentations in the HBN, the inclusion of datasets of varying quality creates a 
unique opportunity to test for associations with participant-related variables of interest beyond 
age and hyperactivity (e.g., anxiety, autistic traits).  
 
4.1.2 Phenotypic Data.​ ​Beyond checking data for outliers, a key question for the evaluation of 
phenotypic data is whether or not the observed distributions and inter-relationships are sensible. 
Figure 2 depicts the distribution of sample variables of interest related to mental health and 
learning. As can be seen, the data obtained for variables known to have a normal distribution 
(e.g., IQ) exhibited a normal distribution in the HBN dataset. Of note, the total score from the 
Child Behavior Checklist, a measure that typically only has meaningful variation among 
symptomatic individuals (resulting in a truncated distribution), was found to have a broad 
distribution in the HBN that was close to normal; this is consistent with the emphasis of HBN 
recruitment on the presence of current concern. 
 
To further facilitate the evaluation of phenotypic data, we plotted correlations between a broad 
sampling of measures included in the HBN (see Figure 3). Statistical relationships observed 
after false discovery rate-based correction for multiple comparisons revealed a wealth of 
associations that are in general alignment with the broader psychiatric literature. For example: 
1) at the most basic level, socioeconomic status (Barratt Simplified Measure of Social Status​42​) 
was positively associated with indices of intelligence (Full scale IQ [FSIQ], Performance IQ 
[PIQ], Verbal IQ [VIQ]) and language performance (i.e., CELF screener), and negatively 
associated with multiple indices of mental illness, 2) general measures of internalizing and 
externalizing symptoms exhibited high correlations with one another, 3) autistic and ADHD traits 
were each negatively associated with performance on intelligence tests, 4) prosocial tendencies 
were higher in those with lower levels of symptoms related to ADHD traits, autistic traits and 
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affective reactivity, 5) higher body mass index was associated with internalizing symptoms and 
increased peer problems. Of note, parent report for anxiety appeared to reveal more robust 
relations with other measures (e.g., autistic traits) than did child self-report, consistent with 
expected rater-bias effects.  
 
4.1.3 Imaging Data. ​Consistent with recent major FCP/INDI data releases (i.e., the Consortium 
for Reliability and Reproducibility [CoRR]​43​, Autism Brain Imaging Data Exchange 2 [ABIDE 
2]​44​), we made use of the Preprocessed Connectome Project Quality Assurance Protocol 
(QAP)​45​ to assess data quality for core MRI data modalities (i.e., functional MRI, morphometry 
MRI and diffusion MRI). The QAP includes a broad range of quantitative measures that have 
been proposed for assessing image data quality (see Table 9 for list of measures and their 
definitions, adapted from​44​).  
 
Given commonly cited concerns about head motion during MRI scans, particularly during resting 
state fMRI scans, we examined age-related differences in motion. We quantified head motion 
using frame-wise displacement (FD), which is calculated using root mean square deviation ​46​. 
Mean FD is commonly used to evaluate the impact of movement on a dataset​47,48​, but it cannot 
distinguish between occasional large movements and frequent smaller movements, the effects 
of the former being likely easier to fix using motion scrubbing or volume censoring methods​47​. 
Consistent with this concern, Figure 4 panel A demonstrates a nonlinear relationship between 
mean FD and median FD, with the latter providing a better indication of the amount of the data 
that can be retained after movement correction (e.g., volume censoring).  
 
Consistent with prior work​49​, both sites (the 1.5 Tesla mobile scanner in Staten Island and the 
3.0 Tesla fixed scanner at Rutgers University) exhibited negative associations between age and 
head motion for all functional scan types, with children between ages 5 and 8 exhibiting the 
greatest levels of movement. Median FD tended to be higher during the second half (5 minutes) 
of the resting state scan than during the first half; this observation resulted in our decision to 
split the scan into two 5-minute scans starting with participant 538 in February 2017. As 
predicted by recent work highlighting the advantages of naturalistic viewing to minimize head 
motion, we found that head motion was significantly reduced during each of the movie-watching 
scan sessions (“Despicable Me” [n = 307], “The Present” [n = 251]) relative to rest.  
 
Beyond the examination of temporal characteristics of the HBN data, we also applied the 
structural measures included in the PCP QA to each of the core data types (functional, diffusion, 
morphometry). See Figure 5 for a subset of these measures; the full set of measures are 
included on the HBN website in a comma-separated tabular format for download.  
 
4.1.4 Associations Between Imaging QA and Clinical Variables. ​With the range of clinical 
presentations and ages present in the HBN, there is a unique opportunity to test for associations 
between phenotypes and dimensions of data quality. Figure 6 depicts significant relationships 
detected between phenotypic variables and QAP parameters for the different scans, using 
Pearson correlation (only significant relationships, surviving false discovery rate correction for 
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multiple comparisons, are depicted). Not surprisingly, for fMRI, age was negatively associated 
with nearly all motion indices, regardless of scan type. Interestingly, while motion parameters 
were correlated with an ADHD measure of hyperactivity during the rest condition, they did not 
correlate significantly during the movie conditions; these findings are in accord with the 
suggestions of prior work examining the impact of movies on head motion ​50​. The quality 
assurance associations with behavioral variables of interest highlighted here are not intended to 
be dissuasive, but rather to emphasize the importance of considering and accounting for the 
potential contributions of data quality to higher order analyses. 
 
4.1.5 EEG Data.​ ​For each of the EEG acquisitions, ​Figure 7 ​ depicts the number of channels 
rejected based on the data distribution and variance of channels (threshold: > 3 standard 
deviations), as implemented in EEGLAB's ​pop_rejchan.m​ function ​51​. 
 
4.1.6 Sampling Biases and Representativeness. ​Although relatively early in recruitment, 
there is sufficient data to obtain insights into potential biases arising in the HBN sample, as well 
as its representativeness of the general population. One of the most notable biases is the 
over-representation of males relative to females in the first release (2:1) (Figure 8). A few factors 
may account for this. First is the prevalence of ADHD in the sample, a disorder that is commonly 
estimated to have 3:1 male:female ratio in children (Figure 9). The prominence of ADHD in the 
sample is not surprising as it is among the most prevalent childhood disorders, and given that it 
is an externalizing disorder, it is much less likely to go unnoticed than internalizing disorders 
(e.g., current estimates suggest that as many as 80% of individuals with anxiety disorders go 
undiagnosed and untreated)​52​. Another factor contributing to prominence of ADHD may be the 
current age distribution; median age in the initial release is 10.7 years old, with an interquartile 
range of 7.8-13.3 (Figure 8). Heavier weighting towards childhood and early adolescence may 
explain lower rates of internalizing relative to externalizing disorders. Future recruitment will 
include targeted efforts to increase the representation of internalizing disorders and older 
adolescents. Similarly, as sample size continues to grow and the additional diagnostic research 
center intended for Harlem is added, we will monitor community variables (e.g., household 
income, parental education, parental marital status, and race/ethnicity). 
 
5. USAGE NOTES. 
5.1 Handling Head Motion in MRI Data. ​Head motion presents an unavoidable challenge for 
developmental and clinical imaging, regardless of MRI modality (fMRI, dMRI, sMRI). Arguably, 
the most basic strategy for handling motion, short of applying an uncomfortable 
motion-restricting apparatus, is limiting analyses to high-quality data. The Brain Genomic 
Superstruct data release is an excellent example of the utility of large-scale datasets in 
supporting such a strategy, as 1,570 datasets were selected for analyses from a pool of 3,000 
individuals following rigorous quality control ​53​. A limitation of this strategy for psychiatric data is 
that many phenotypes of interest are inherently more prone to head motion (e.g., children under 
9, those with Attention-Deficit/Hyperactivity Disorder), especially those with higher symptoms 
levels. Compounding the downsides of discarding data are the increased costs associated with 
the recruitment and phenotyping of clinical populations.  
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For functional MRI, an alternative strategy is to statistically correct the data for 
movement-induced intensity fluctuations, or remove offending time frames altogether​47​. This can 
be accomplished by a number of means, ranging from regressing a model of movement from 
the data (e.g., spike regression ​54​), removing the contributions of motion-related spatial patterns 
from the data (AROMA​55​), attenuating motion spikes using a squashing function, removing 
offending frames, zeroing out offending frames, or deleting offending frames followed by 
interpolation. More generalized correction approaches, such as global signal regression and 
forms of white matter and cerebrospinal fluid regression (e.g., tCompCor, aCompCor​56,57​) can 
also help to account for motion artifacts. While there is no consensus approach to date, there is 
a growing literature focused on providing benchmark evaluations of these approaches, as well 
as their relative merits and weaknesses (e.g., see ​48​,​58​), that can be used to help select among 
these corrections. 
 
More broadly, group-level statistical corrections can be used to account for the contributions of 
motion-related artifacts to associations revealed through data analysis​54​. In the case of 
functional MRI, this can be accomplished by including motion parameters as a statistical 
covariate at the group level. Given the trait nature of head motion ​43​, some have advocated for 
using fMRI-derived motion parameters in structural analysis as well. Alternatively, accounting for 
full-brain differences in measures of interest at the group-level has been shown to be a 
potentially valuable approach to minimizing the deleterious effects of motion, particularly for 
fMRI​58​. 
 
It is our hope that the breadth of the Healthy Brain Network dataset will provide a practical 
perspective of the challenges of motion for various domains of illness and help to stimulate 
continued development and testing of novel correction strategies.  
 
5.2 Special Opportunities.  
The HBN Biobank is intended to be a resource for accelerating the pace of scientific 
advancement for neurodevelopmental and learning disorders, and accomplishing this goal will 
require the combined expertise of a wide range of disciplines. From high-performance 
computing strategies for addressing the scale of the data, to new analytical strategies for 
performing regressions on graphs, and better instruments for assessing dimensions of cognitive 
development, there are a variety of ways researchers can use these data. Below are a few 
research questions that we believe will be particularly suitable for these data.  
 
5.2.1 Advancing Biophysical Modeling (EEG, fMRI, dMRI).​ Mathematical models are an 
increasingly popular tool for establishing links between brain function and structure. Although 
still early in their development, recent applications have demonstrated the ability of biophysical 
models to make predictions about patterns of brain function assessed using fMRI and EEG, as 
well as behavior​59,60​. The inclusion of fMRI, EEG and diffusion imaging in the HBN will help 
investigators to build bridges between these three modalities, as well as the underlying 
morphology, for which increasingly sophisticated characterizations are being afforded by 
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automated pipelines, such as MindBoggle ​61​. Such models can also be useful for developing and 
testing hypotheses about possible mechanisms underlying variations in behavior, as well as the 
occurrence of disease states. Additionally, researchers will be able to test the ability to compare 
the result of EEG-based functional connectivity analyses carried out in source space (i.e., 
anatomical space following source localization), with those obtained using functional MRI; such 
comparisons are important for those interested in the development of clinical tools, as EEG is 
easier to administer and has lower costs.  
  
5.2.2 Naturalistic Viewing EEG and fMRI. ​A growing literature over the past decade supports 
naturalistic viewing EEG and functional MRI​62–64​. Akin to the arguments for resting state fMRI 
methods nearly a decade ago, advocates highlight findings of reliability for various phenomena 
observed with naturalistic viewing, as well as the potential to assess inter-individual 
differences​65​. Recent works have suggested that naturalistic viewing may yield equivalent or 
even superior levels of reliability for the assessment of functional connectivity relative to rest​66,67​, 
with the potential to yield novel functional connectivity measures (e.g., inter-subject functional 
connectivity)​68​. Finally, this experimental paradigm can be used for the study of temporal 
dynamics in the brain ​68​. To facilitate the translation of findings between EEG and fMRI, the 
animated film titled “The Present” is now included in both the HBN EEG and fMRI protocols.  To 
date, 248 participants have watched “The Present” during EEG, 251 participants have watched 
during fMRI, and 129 participants have watched during both EEG and fMRI.  
 
5.2.3 Questionnaire refinement and applications of item response theory.​ ​A key reality for 
biologically focused studies is that the potential for discovery is limited by the quality and 
breadth of phenotyping. The breadth of questionnaires and measures in the HBN provides 
opportunities for deriving optimal measure sets that minimize the number of items required to 
characterize an individual while maximizing their predictive value. Beyond traditional factor 
analyses, item response theory​69–71​ is promising to accelerate the process of finding those 
questions or measures that are most essential for characterizing differences between 
individuals.  
 
5.2.4 Voice analysis for biomarker identification.​ Extraction and analysis of high-dimensional 
feature sets to characterize vocal production, speech patterns, and speech content is a 
promising direction for biomarker identification. Features characterizing vocal production are 
independent of speech content itself, and can provide objective measures of motor difficulties as 
well as independent means of assessing psychiatrically relevant states, such as mood and 
anxiety. Features related to patterns and content of speech provide additional opportunities to 
characterize more complex emotional and cognitive states, as well as issues related to 
processing information and expressing thoughts. Coupled with other behavioral assessments in 
the HBN protocols, voice and speech data will encourage users of the HBN data to consider 
richer and more nuanced approaches to analyzing phenotypic data.  
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AVAILABILITY OF SUPPORTING DATA. 
 
LIST OF ABBREVIATIONS 
ABCD: Adolescent Brain Cognitive Development 
ABIDE: Autism Brain Imaging Data Exchange 
ADHD: Attention-Deficit/Hyperactivity Disorder 
ADOS: Autism Diagnostic Observation Schedule 
AROMA: Automatic Removal of Motion Artifacts 
BIA: Bioelectrical Impedance Analysis 
CELF-5: Clinical Evaluation of Language Fundamentals, 5th Edition 
CMI: Child Mind Institute 
COINS: COllaborative Informatics and Neuroimaging Suite 
CoRR: Consortium for Reliability and Reproducibility 
CTOPP: Comprehensive Test of Phonological Processing 
CUNY: City University of New York 
dMRI: diffusion magnetic resonance imaging 
DSM-5: Diagnostic and Statistical Manual of Mental Disorders, 5th Edition 
DUA: data usage agreement 
EEG: electroencephalogram 
EGI: Electrical Geodesics, Inc. 
EVT: Expressive Vocabulary Test 
FCP: 1000 Functional Connectomes Project 
fMRI: functional magnetic resonance imaging 
FSIQ: full scale intelligence quotient 
GFTA: Goldman Fristoe Test of Articulation 
HBN: Healthy Brain Network  
HIPPA: Health Insurance Portability and Accountability Act 
IEP: Individualized Education Plan 
INDI: International Neuroimaging Data-sharing Initiative 
IQ: intelligence quotient 
IRB: Institutional Review Board 
KBIT: Kaufman Brief Intelligence Test 
KSADS: Schedule for Affective Disorders and Schizophrenia for Children 
LORIS: Longitudinal Online Research and Imaging System 
MRI: magnetic resonance imaging 
NIH: National Institutes of Health 
NKI: Nathan Kline Institute 
NY: New York 
NYC: New York City 
PHI: protected health information 
PIQ: performance intelligence quotient 
PPVT: Peabody Picture Vocabulary Test 
QA: quality assurance 
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QAP: quality assurance plan 
RUBIC: Rutgers University Brain Imaging Center 
RV: research vehicle 
SMI: SensoMotoric Instruments 
sMRI: structural magnetic resonance imaging 
TOWRE: Test of Word Reading Efficiency 
VIQ: verbal intelligence quotient 
WAIS-IV: Wechsler Adult Intelligence Scale, 4th Edition 
WASI: Wechsler Abbreviated Scale of Intelligence 
WIAT-III: Wechsler Individual Achievement Test, 3rd Edition 
WISC-V: Wechsler Intelligence Scale for Children, 5th Edition  
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Figure Legends: 
Figure 1. ​HBN Protocol Timeline. ​Here we depict the month in which each assessment was 
added (and in some cases removed).  Dark gray boxes indicate inclusion of the assessment in 
the protocol for a given month, while white boxes indicate the measure was not included.  
Figure 2.​ ​Distribution of IQ measures and CBCL Scores.​ Participant IQ was measured using the 
WISC, with the exception of: 1) early participants for whom the more abbreviated WASI was 
performed, 2) individuals with limited verbal skills and/or known IQ less than 70, or 3) children 
under age 6.  For these latter two cases, the KBIT was performed. These figures include overall 
performance IQ, verbal IQ, and full-scale IQ measures from all three tests.  
Figure 3.​ Correlation Matrix of HBN Phenotypic Measures:​ Heatmap depicts significant 
correlations between a broad sampling of HBN behavioral, cognitive, and physical measures 
after multiple comparisons correction (false discovery rate; q < 0.05). The associations revealed 
are in general alignment with the broader psychiatric literature.  
Figure 4. ​Median Framewise Displacement Measures.​ The upper left panel plots Median 
Framewise Displacement (Median FD) vs. Mean Framewise Displacement (FD) for Staten 
Island (SI) and Rutgers (RU) fMRI. The upper right panel shows the difference in median FD 
between different scan conditions. The bottom panel shows median FD for different scan types 
for different ages. Significance values depicted reflect results of paired t-test. 
Figure 5. ​Preprocessed Connectome Project Quality Assurance Measures for functional and 
morphometric MRI.​ Shown here are PCP QA results for morphometry (upper panel) and 
functional (lower panel) MRI data quality for each data acquisition phase - Staten Island (SI; 1.5 
Tesla Siemens Avanto) and Rutgers (RU; 3.0T Siemens Tim Trio).  
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Figure 6. ​Correlation Between Phenotypic Measures and QAP measures. ​Here we depict 
significant Pearson correlations (after false discovery rate correction for multiple comparisons) 
between phenotypic measures and key QA indices for morphometry MRI (left panel), as well as 
each of the functional MRI scan types (resting state fMRI, naturalistic viewing fMRI: ‘Despicable 
Me’, naturalistic viewing fMRI: ‘The Present’) (right panel). To facilitate visualization, significance 
values are depicted as -log10(p). 
Figure 7.​ ​EEG quality assessment: Shown here are the number of rejected EEG channels for 
each of the paradigms. 
Figure 8.​ ​Age and Sex Distribution of HBN Participants. 
Figure 9.​ ​Diagnostic Breakdown of HBN Participants. ​This figure shows the frequency of 
diagnoses given to HBN participants.  Data for this figure comes from the final consensus 
diagnosis given by the lead clinician at the end of participation.  Diagnoses are grouped by 
category. 
 
Table Legends: 
Table 1.​ Participant Inclusion and Exclusion Criteria. 
Table 2.​ Healthy Brain Network Project Plan. 
Table 3.​ HBN Visit Schedule, Manhattan and Staten Island Offices. 
Table 4.​ ​Complete HBN Protocol. 
Table 5.​ HBN Diagnostic Specific Assessments. 
Table 6.​ ​Description of EEG Paradigms. 
Table 7.​ MRI Protocol Layout. 
Table 8.​ ​MRI Protocol Parameters. 
Table 9.​ ​Description of the Preprocessed Connectome Project (PCP) Quality Assurance 
Protocol (QAP) Measures. 
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Table 1. Participant Inclusion and Exclusion Criteria 
 
 
 
 
  
	
Inclusion	Criteria	
1. Male	or	female	ages	5	-	21	years.	
2. Adults	must	have	capacity	to	understand	the	study	and	provide	informed	consent.	
a. Children	ages	5-17	must	have	the	capacity	to	provide	assent	(	must	speak	in	simple,	but	
full	(3+	word)	sentences	at	the	Kindergarten	level)	and	parent/guardian						must	have	the	
capacity	to	sign	informed	consent.	
3. Participants	must	be	fluent	in	English.	Children	who	are	fluent	in	English	but	have	parents						
who	speak	Spanish	can	be	enrolled	upon	availability	of	Spanish-speaking	personnel.	
Exclusion	Criteria	
1. Serious	neurological	(specific	or	focal)	disorders	preventing	full	participation	in	the	protocol.	
Some	children	with	moderate	to	severe	impairment	in	cognitive	(i.e.,	IQ	below	66)	and/or	
general	function	will	be	eligible	for	a	short,	research-based	protocol.	Parents	will	be	informed	
that	this	battery	will	not	allow	for	a	full,	comprehensive	feedback	report.	A	feedback	session		
and	abbreviated	report	will	be	provided.		
a. Examples	include:	non-verbal	and/or	low	functioning	autism,	placement	in	classroom	
environment	lower	than	12:1:1,	chronic	epilepsy.		
2. Childhood	metabolic	disorders	(i.e.,	disorders	of	lipid,	carbohydrate,	metal,	amino	acid,	etc.).	
3. Positive	HIV	status.	
4. Renal	or	liver	failure.	
a. Must	be	current,	acute	failure.	Past	liver	or	kidney	disease	that	was	treated	to	remission	
confers	eligibility.	
5. Current	or	past	diagnosis	of	encephalitis.	
6. Known	neurodegenerative	disorder	(e.g.	Huntington’s	Disease,	ALS,	MS,	Cerebral	Palsy).	
7. Hearing	or	visual	impairment	that	prevents	participation	in	study-related	tasks.	
a. Child	can	participate	if	vision	or	hearing	is	corrected	with	devices.	
8. Current	history	(within	the	past	6	months)	of	Schizophrenia,	Schizoaffective	Disorder,	or			
Bipolar	Disorder.	
a. The	absence	of	a	formal	diagnosis	confers	eligibility.	
9. Manic	or	psychotic	episode	within	the	past	6	months	without	current,	ongoing	treatment.	
10. New	onset	(within	the	last	3	months)	of	suicidality	or	homicidality	for	which	there	is	no	
current,	ongoing	treatment.	
a. This	can	be	ideation	or	a	plan.		It	must	be	believable,	recurrent,	and	bona	fide.	
11. History	of	lifetime	substance	dependence	requiring	chemical	replacement	therapy.	
12. History	of	substance	dependence	within	the	last	year	except	nicotine	and	marijuana.	
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Table 2. Healthy Brain Network Project Plan 
Project Plan Goals 
Phase I: Implementation and Testing (N=500) 
• Establish project workflows 
§ Mental health diagnostic evaluation 
§ Phenotypic assessment  
§ EEG  
§ MRI scanning 
• Establish prototypes for Diagnostic 
Research Center (HBN-Staten Island) 
• Test utility of mobile Diagnostic 
Research Center 
• Test utility of mobile MRI platform 
• Establish recruitment sources and 
community partners 
Phase II: Revision and Hardening (N=500) 
• Augment learning and language 
evaluation protocols  
• Increase breadth of phenotyping and 
overlap with other initiatives 
§ Family history 
§ Impairment 
§ Prenatal assessment 
§ Parental distress 
§ Sleep 
§ Stress/trauma 
§ Substance use 
• Identify and troubleshoot data quality 
issues 
• Introduce voice assessment protocols 
• Introduce saliva collection for genetics 
• Introduce natural viewing fMRI 
• Introduce home-based longitudinal 
follow-up (HBN Quarterly Mental  Health 
Report) 
• Optimize staffing models and workflow 
efficiencies 
• Test and harden KSADS-COMP  
• Test and harden E-SWAN 
• Test reproducibility of prototype 
Diagnostic Research Center         (HBN-
Manhattan) 
Phase III: Scale-up (N=8,500) 
• Increase to three full-scale Diagnostic 
Research Centers 
• Transition to multi-site stationary MRI 
scanner model 
• Implement infrastructure for 
epidemiologic sampling 
• Introduce home-based phlebotomy 
collection model  
• Introduce actigraphy 
Phase IV: Targeted Recruitment (N=1,000) 
• Epidemiologic sampling 
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Table 3. HBN Visit Schedule, Manhattan and Staten Island Offices 
 
Time	(min) Child	Activity Parent	Activity
30 Introduction,	consent
15 Assent Enrollment,	MRI	screening
75 WISC/WASI/KBIT Pre-Interview	I	(clinical	portion)
30 	Child	questionnaires
15 Mock	scanner
Time	(min) Child	Activity Parent	Activity
105 MRI	scan
Time	(min) Child	Activity Parent	Activity
45-69 WIAT Pre-Interview	II:	RA	portion
20-30 CELF-5	and	TOWRE
30 NIH	Toolbox
60 Child	questionnaires
30 Fitness/vitals
Time	(min) Child	Activity Parent	Activity
75-90 EEG KSADS
40-45 KSADS
30 Quotient
30 CTOPP	and	GFTA
Visit	One
Visit	Two
Visit	Three
Visit	Four
Parent	questionnaires
Healthy	Brain	Network	Visit	Schedule
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Table 4. Complete HBN Protocol 
 
Behavioral Measures
Child Behavior Checklist (CBCL) (5-17)
Youth Self Report (YSR) (11-18)
Adult Self Report (ASR) (18+)
Screen for Child Anxiety Related Disorders (SCARED) – Parent Report & Self Report (8-18)
State Trait Anxiety Inventory (STAI) (18+) – Self Report
Mood & Feelings Questionnaire (MFQ) – Parent Report & Self Report (8+)
Affective Reactivity Index – (ARI-S) Self Report 
Columbia Suicide Severity Rating Scale (C-SSRS) – Self Report (7+)
Extended Strengths and Weaknesses Assessment of Normal Behavior (E-SWAN) (5-17)
Strengths and Weaknesses of ADHD Symptoms and Normal Behavior Scale (SWAN) (6+)
Conners ADHD Rating Scales Self Report Short Form (Conners) (8+)
Repetative Behavior Scale (RBS) (5-21)
Autism Spectrum Screening Questionnaire (ASSQ) (5+)
Social Communication Questionnaire (SCQ) (5+)
Social Responsiveness Scale-2 (SRS-2) (5+)
Strengths and Difficulties Questionnaire (5+)
The Columbia Impairment Scale (CIS) Parent ad self report (5+)
Social Aptitudes Scale (SAS) (5+)
WHO Disability Assessment Schedule (WHODAS) Parent and Self-Report (5+)
Food Frequency Questionnaire (FFQ) (5-17)
Inventory of Callous-Unemotional Traits - Parent Report (5+)
Family Structure, Stress and Trauma
Family History-Research Diagnostic Criteria (FH-RDC)
Parental Stress Index IV (PSI-IV)
Alabama Parenting Questionnaire – Self Report (APQ) (6-18)
Alabama Parenting Questionnaire – Parent Report (APQ) (6-18)
Children’s Perception of Interparental Conflict (CPIC) (8-18)
Distress Tolerance Index – Parental Self Report
Children’s Coping Strategies Checklist – Revised (CCSC) (8-18)
UCLA Trauma Reactivity Sale for DSM-V (UCLA) (5-18)
Negative Life Events Scale (NLES)  – Self Report (8-18)
Negative Life Events Scale Parent Report (8-18)
Adverse Childhood Experiences Scale (ACES) (18+)
Substance Use and Addiction Measures
Fagerstrom Test for Nicotine Dependence (FTND) (18+)
Alcohol Use Disorders Identification Test (AUDIT) (11+)
Modified Fagerstrom Tolerance Questionnaire- Adolescents (FTQA) (13-17)
European School Survey Project on Alcohol & Other Drugs (ESPAD) (10+)
Internet Addiction Test (IAT) 
Parent-Child Internet Addiction Test (PCIAT)
Yale Food Addiction Scale (YFAS) and YFAS-Child
Longitudinal Follow Up Measures
Youth Services Survey (YSS) & Services Assessment for Children and Adolescents (SACA)
Follow Up: CBCL
Follow Up: Columbia Impairment Scale Parent snd Self Report
Follow Up: WHODAS Parent and Self Report 
General Information
Demographics  
CMI Symptom Checker
Edinburgh Handedness Inventory 
Intake Interview
Physical Activity Questionnaire for Older Children (PAQ-C) (8-14)
Physical Activity Questionnaire for Adolescents (PAQ-A) (14-19)
Barratt Simplified Measure of Social Status
Financial Support Questionnaire
Medical History Questionnaire – Family
Pregnancy and Birth Questionnaire
Physical Measures
FITNESSGRAM (Pushups, Curl-ups, Trunk-Lift, Sit and Reach, Grip Strength)
Cardiovascular Fitness Test
Vitals (Heart Rate, Blood pressure)
Measurements (Height/weight, Waist circumference, Bio-impedance)
Blood Draw (Endocrine, Immunologic, and Metabolic profiling; Genetics)
Buccal Swabs (Genetics)
Urine Sample (Toxicology screen, Pregnancy test: 11+)
Ishihara Color Vision Test
Electroencephalography (EEG)/Eye Tracking
Magnetic Resonance Imaging (MRI)
Peterson Puberty Scale (6-17)
Sleep Disturbance Scale for Children (SDSC) (6-15)                                         
Cognition and Language Tasks
NIH Toolbox Tasks: Flanker, Card Sort and Processing Speed
Temporal Discounting Task 
Quotient ADHD System
Rapid Automatic Naming & Rapid Alternating Stimulus Test (RAN/RAS) (5)
Wechsler Intelligence Scale for Children-V (WISC-V) (6-17)
Wechsler Adult Intelligence Scale-IV (WAIS-IV):  (17+)
Wechsler Abbreviated Scale of Intelligence-II (WASI): (17+)
Wechsler Individual Achievement Test – III (WIAT) 
Differential Ability Scales – II  (DAS) (5 or IQ below 70)
Clinical Evaluation of Language Fundamentals – 5th Edition (CELF-5)
Goldman Fristoe Test of Articulation – II (GFTA)
Comprehensive Test of Phonological Processing – II (CTOPP)
Test of Word Reading Efficiency (TOWRE) (6+)
Expressive Vocabulary Test (EVT) (when indicated)
Peabody Picture Vocabulary Test (PPVT) (when indicated)
Diagnostic Assessments
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) 
Child and Adolescent Psychiatric Assessment Schedule (Cha-PAS) (when indicated)
Vineland Adaptive Behavior Scale – Parent/Caregiver Rating Form (when indicated)
Yale Global Tic Severity Scale (YGTSS) (when indicated, 6+)
Yale-Brown Obsessive Compulsive Scale (Y-BOCS) (when indicated, 18+)
Children’s Yale-Brown Obsessive Compulsive Scale (when indicated, 6-18)
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Table 5. HBN Diagnostic Specific Assessments 
 
  
Diagnosis Assessment Description
Autism Diagnostic 
Interview – Revised 
(ADI-R)
A reliable and valid standardized diagnostic interview developed to 
aid practitioners in gathering a complete developmental history and 
current functioning level for an individual being evaluated for ASD. 
Administered to participants with a referral for autism-specific 
evaluation.
Autism Diagnostic 
Observation Schedule, 
2nd edition (ADOS-2)
A standardized, semi-structured play-based assessment in which 
tasks are presented in a standardized manner to elicit and/or 
highlight the presence or absence of specific behaviors relevant to 
making an ASD diagnosis. Administered to participants with a 
referral for autism-specific evaluation.
Vineland Adaptive 
Behavior Scale – 
Parent/Caregiver 
Rating Form
A measure of adaptive behavior from birth to adulthood; forms an 
aid in diagnosing and classifying intellectual and developmental 
disabilities. Administered to parents of participants with 
developmental or intellectual disorders.
Child and Adolescent 
Psychiatric 
Assessment Schedule 
(ChA-PAS)
A semi-structured clinical interview linked to a clinical glossary that 
guides the ratings. The ChA-PAS has, however, been extended to 
include ADHD and Behavioral Disorders, as well as axis I psychiatric 
disorders. It also includes a screen for autistic spectrum disorders. 
Administered to parents of participants with developmental or 
intellectual disorders.
Clinical Evaluation of 
Language 
Fundamentals – Fifth 
Edition (CELF-5)
An individually administered assessment tool made up of 18 
subtests organized into four levels of testing that address language 
content, structure, and use. Administered to children with a referral 
for an extended language evaluation.
Test of Language 
Competence – 
Expanded Edition 
(TLC-E) Level 1
An individually administered, norm-referenced oral language 
measure which evaluates for delays in the emergence of linguistic 
competence and in the use of semantic, syntactic, and pragmatic-
strategies. An emphasis is placed on assessing within the contextual 
and situational demands of conversation in addition to basic 
semantic and syntactic abilities. Administered to children with a 
referral for an extended language evaluation.
Expressive Vocabulary 
Test, Second Edition 
(EVT-2)
An individually administered, norm-referenced instrument that 
assesses expressive vocabulary and word retrieval for children and 
adults. Administered to children with a referral for an extended 
language evaluation.
Peabody Picture 
Vocabulary Test, 
Fourth Edition (PPVT-
4)
A norm-referenced, wide-range instrument for measuring the 
receptive (hearing) vocabulary of children and adults. For each item, 
the examiner says a word, and the examinee responds by selecting 
the picture that best illustrates that word’s meaning. Administered to 
children with a referral for an extended language evaluation.
Goldman-Fristoe Test 
of Articulation - III 
(GFTA-3)
Provides information about a child’s articulation ability by sampling 
both spontaneous and imitative sound production. Use this test to 
measure articulation of consonant sounds, determine types of 
misarticulation, and compare individual performance to national, 
gender-differentiated norms. Administered to children with a referral 
for an extended language evaluation.
Obsessive 
Compulsive 
Disorder (OCD)
Yale-Brown Obsessive 
Compulsive Scale (Y-
BOCS)
A semi-structured clinician-rated instrument that assesses the 
severity of OCD symptoms. Administered as part of KSADS 
interview, if indicated.
Tic Disorder
Yale Global Tic 
Severity Scale (Y-
GTSS)
A semi-structured clinician-rated instrument that assesses the 
nature of motor and phonic tics. Administered as part of KSADS 
interview, if indicated.
Autism Spectrum 
Disorder
Intellectual 
Disability
Speech/Language 
Disorder
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Figure 1. HBN Protocol Timeline  
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SCARED	-	Parent	&	Self	Report
STAI
Conners	SF	-	Self	Report
CAARS	-	Self	Report
Quotient	ADHD	System
SWAN
ASSQ
SCQ
SRS-2
RBS
Barratt
Demographics
Intake	Interview
Family	History
FSQ
PhenX	School	Risk
PhenX	Neighborhood	Safety
CNB
CGAS
DAS-II
KBIT-II	(Age	5	or	IQ<70)
NIH	Toolbox
RAN/RAS
WAIS-IV	Digit	Span	Only
WAIS-IV	Full	Assessment
WAIT-III	Select	Subscales
WIAT-III	Full	Assessment	
WASI-II
WISC-V
ARI	-	Parent	&	Self	Report
BDI-II
CDI2	-	Parent	&	Self	Report
MFQ	-	Parent	&	Self	Report
CSSRS
ASR
CBCL
YSR
CMI	Symptom	Checklist
SDQ
TRF
E-SWAN
CIS	-	Parent	&	Self	Report
SAS
WHODAS	-	Parent	&	Self	Report
ICU	-	Parent	Report
EEG	Tracking	Data
MRI	Tracking	Data
OCD Y-BOCS
EHQ
FitnessGram
ColorVision	Test
PAQ-A
PAQ-C
Physical
Tanner	Staging
Peterson	Puberty	Scale
PBQ
FFQ
K-SADS
ChA-PAS
Vinelan
Sleep SDS
ACES
APQ	-	Parent	&	Self	Report
CCSC
CPIC
UCLA	Trauma
NLES	-	Parent	&	Self	Report
PSI-4
DTS
AUDIT
FTND
FTQA
NIDA
ESPAD
IAT	-	Parent	&	Self	Report
YFAS
Tics YGTSS
CELF	5	Screen
CTOPP-II
TOWRE-II
CELF	5
PPVT4
EVT2
GFTA-III
2015 2016 2017
Background	
Information	
and	
Demographics
ADHD
ASD
Substance	
Abuse/Addictiv
e	Behavior
Anxiety
Family	
Structure,	
Stress	and	
Trauma
Verbal	Learning
Multiple	
Disorders
Cognitive	and	
Executive	
Functioning
Depression	and	
Mood
Neuroimaging
Physical
Diagnostic	
Measures
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Table 6. Description of EEG Paradigms 
 
Adapted from: Langer N et al. (2017) 
A resource for assessing information processing in the developing brain using EEG and eye tracking Sci Data, 4:	170040 
  
Task Degree of stimulation Description Duration Reference
Participants are asked to observe and memorize of a sequence of 
either five or ten stimuli, depending on age. The sequence is repeated 
across five trials.
The purpose of the paradigm is to track the progress of gradual 
memory formation. Trials are categorized as “hits,” “misses,” or 
“learned,” and event-related potentials are measured for hits and 
misses. Analysis of this paradigm will examine whether two specific 
ERPs, N2 and P3, are modulated during this sequence. 
This paradigm consists of a series of tasks in which for each trial, 
participants fixate on a central point on the screen while a set of 
semantically unloaded stimuli appear. The participant discriminates a 
stimulus feature such as color, orientation, or shape and indicates the 
decision by either button press or eye movement. 
Reaction time, accuracy, latency, and amplitude of Steady State 
Visually Evoked Potentials (SSVEPs) are measured 
For each trial in the symbol search paradigm, participants are shown 
rows of two target symbols and five symbols, and asked to mark 
whether or not one of the target symbols appears in one of the five 
subsequent symbols.
The paradigm is a computerized version of a clinical pediatric 
assessment intended to measure processing speed capacity. Eye 
tracking is used to gather information about how long participants look 
at each symbol and their strategy for completing the task. 
Participants view a fixation cross on the center of the computer 
screen. Throughout the paradigm, participants are instructed to open 
or close their eyes at various points.
The paradigm is intended to measure endogenous brain activity during 
rest.
The stimulus used for this paradigm consists of four small flickering 
discs embedded in a static grating background. The discs generate 
strong steady-state responses that vary with contrast of the sound.
The paradigm is intended to measure excitatory (SSVEP) and 
inhibitory (surround suppression) neurophysiological activity.
Participants view a montage of short video clips taken from age-
appropriate, mainstream television and movies.
Stimuli include the following:
Despicable Me (Clip from feature-length film; 3 mins)
Diary of a Wimpy Kid (Trailer for feature-length film; 2 mins)
“Fun with Fractals” (Educational video clip; 4.5 mins)
The Present (Short film; 4.5 mins)
The purpose of this paradigm is to measure neurophysiological activity 
during higher-level audio-visual stimulation. 
Regan,	D.	Human	Brain	
Electrophysiology:	Evoked	
Potentials	and	Evoked	Magnetic	
Fields	in	Science	and	Medicine	
(Elsevier,	1989).;	Regan,	D.	An	
effect	of	stimulus	colour	on	
average	steady-state	potentials	Hasson,	U.,	et	al.	Intersubject	
synchronization	of	cortical	
activity	during	natural	vision.	
Science	303,	1634–1640	(2004).;	
Hasson,	U.,	et	al.	Reliability	of	
cortical	activity	during	natural	
stimulation.	Trends	in	cognitive	
sciences	14,	40–48	(2010).;	
Bartels,	A.	&	Zeki,	S.	Functional	
brain	mapping	during	free	
viewing	of	natural	scenes.	
Human	brain	mapping	21,	75–85	
(2004).
Active (task-dependent paradigms)
Passive (task-independent paradigms)
5	mins
Moisello,	C.	et	al.	Neural	
activations	during	visual	
sequence	learning	leave	a	trace	
in	post-training	spontaneous	
EEG.	PLoS	ONE	8,	e65882	
(2013).
O'Connell,	R.	G.,	Dockree,	P.	M.	
&	Kelly,	S.	P.	A	supramodal	
accumulation-to-bound	signal	
that	determines	perceptual	
decisions	in	humans.	Nature	
neuroscience	15,	1729–1735	
(2012).
Wechsler,	D.	The	Wechsler	
intelligence	scale	for	children.	
4th	edn	(Pearson,	2004).
Fox,	M.	D.	&	Greicius,	M.	Clinical	
applications	of	resting	state	
functional	connectivity.	
Frontiers	in	systems	
neuroscience	4,	19	(2010).
14	mins	
total
3.5	mins
5	mins
2	mins
9	mins									
(3	runs	of	
3	minutes	
each)
Naturalistic Stimuli 
Paradigm Complex
WISC-IV Symbol 
Search Paradigm Complex
Resting-State None
Inhibition/Excitation 
Paradigm Minimal
Sequence Learning 
Paradigm Moderate
Visual 
Perception/Decision-
making Paradigm
Moderate
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Table 7: MRI Protocol Layout  
 
  
Scan	Type Time	(min) Scan	Type Time	(min)
Abdomen	localizer 0.52 Localizer 0.2
T2Flair 2.73 T2Flair 2.4
Breathhold 0.18 fMRI	Distortion	map 0.1
Brain	localizer 0.43 fMRI	Distortion	map 0.1
motion	training 1.58 Rest 5.1
field	map 1.08 Peer	1 1.9
Resting	state 10.3 Rest 5.1
T1W 6.53 Peer	2 1.9
DWI	B=0	PA-AX 0.27 Movie:	Despicable	Me 10
DKI	64	Directions	AP 9.98 T1W 7
DWI	B=0	PA-AX 0.27 T2Space 7
DWI	B=0	AP-AX 0.27 Peer	3 1.9
Despot	1 5 Movie:	The	Present 4
IR	SPRG 0.88 MT	On 4
Despot	2 5 MT	Off 4
MT	Off 6.68 DKI 10
MT	On 6.68 64.7
58.4
Rutgers	UniversityStaten	Island	
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Table 8: MRI Protocol Parameters 
  
 
  
Slices %FOV	phase Resolution(mm) TR	(ms) TE	(ms) TI	(ms) Flip	Angle	(°) Multi	Band	Accel Phase	Partial	Fourier Notes
T1	MPRAGE 176 100% 	1.0	×	1.0	×	1.0 2730 1.64 1000 7 N/A Off
T2	FLAIR 24 87.50% 	0.9	×	0.9	×	5.0 9000 89.00 2500 150 N/A Off
Diffusion 72 100% 2.0	×	2.0	×	2.0 3110 76.20 N/A 90 3 6/8 64	directions,	b	=	0,1000,2000
fMRI 54 100% 2.5	×	2.5	×	2.5 1450 40.00 N/A 55 3 Off
MTI 176 100% 1.0	×	1.0	×	1.0 30 11.00 N/A 15 N/A 6/8 Acquired	with	and	without	MT
Slices %FOV	phase Resolution(mm) TR	(ms) TE	(ms) TI	(ms) Flip	Angle	(°) Multi	Band	Accel Phase	Partial	Fourier Notes
T1	MPRAGE 224 100% 0.8	×	0.8	×	0.8 2500 3.15 1060 8 N/A Off
T2	FLAIR 22 87.50% 0.9	×	0.9	×	5.0 9000 90.00 2500 150 N/A Off
T2	SPACE 224 100.00% 0.8	×	0.8	×	0.8 3200 564.00 N/A varies N/A Off
Diffusion 72 100% 1.8	×	1.8	×	1.8 3320 100.20 N/A 90 3 Off 64	directions,	b	=	0,1000,2000
fMRI 60 100% 2.4	×	2.4	×	2.4 800 30.00 N/A 31 6 Off
MTI 176 100% 1.0	×	1.0	×	1.0 30 11.00 N/A 15 N/A 6/8 Acquired	with	and	without	MT
Rutgers	University
Staten	Island
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Figure 2. Distribution of IQ measures and CBCL Scores 
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Figure 3. Correlation Matrix of HBN Phenotypic Measures 
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Table 9. Description of QAP Measures
 
 
 
Spatial	Metrics Description
Contrast-to-noise	ratio	(CNR)72	(sMRI	only) MGM	intensity—MWM	intensity/SDair	intensity.	Larger	values	reflect	a	better	WM	GM	distinction.
Signal-to-noise	ratio	(SNR)72 MGM	intensity/SDair	intensity.	Larger	values	reflect	less	noise
Artifactual	voxel	detection	(Qi1)73	(sMRI	only)
*	voxels	with	intensity	corrupted	by	artifacts/	*voxels	in	the	background.	Larger	values	reflect	more	
artifacts	which	likley	due	to	motion	or	image	instability.
Entropy	Focus	Criteria	(EFC)74	†
Shannon’s	entropy	of	each	voxel's	intensity	used	to	measure	ghosting	and	blurring	due	to	head	
motion.	Larger	values	reflect	more	blurring	likley	to	motion	or	techincal	differences.
Smoothness	of	Voxels	(FWHM)75	†
Full-width	half	maximum	of	the	spatial	distribution	of	the	image	intensity	values.	Larger	values	reflect	
more	spatial	smoothing	maybe	due	to	motion	or	technical	differences.
Foreground	to	Background	Energy	Ratio	(FBER)	† M	energy	of	image	intensity	(i.e.,	mean	of	squares)	within	the	head	relative	to	that	of	outside	the	
head.	Larger	values	reflect	higher	signal	in	relation	to	noise.
Ghost	to	Signal	Ratio	(GSR)76	†
M	signal	in	the	‘ghost’	image	divided	by	the	M	signal	within	the	brain.	Larger	values	reflect	more	
ghosting	likley	due	to	physiological	noise,	motion,	or	technical	issues.
Temporal	Metrics	(fMRI	*	and	DTI	only) Description
Mean	framewise	displacement-	Jenkinson	(mFD)46	‡
Sum	absolute	displacement	changes	in	the	x,	y	and	z	directions	and	rotational	changes	around	them.	
Rotational	changes	are	given	distance	values	based	on	changes	across	the	surface	of	a	50 mm	radius	
sphere.	Larger	values	reflect	more	movement.
%	and	*	volumes	with	FD>0.2 mm	‡ %	and	*volume	to	volume	motion	>0.2 mm	FD.	Larger	values	reflect	more	movement.
Standardized	DVARS77	‡
Spatial	SD	of	the	data	temporal	derivative	normalized	by	the	temporal	SD	and	autocorrelation.	Larger	
values	reflect	larger	frame-to-frame	differences	in	signal	intensity	due	to	head	motion	or	scanner	
instability.
Outlier	Detection78	†
M	fraction	of	outliers	in	each	volume	per	3dToutcount	AFNI	command.	Higher	values	reflect	more	
outlying	voxels,	which	may	be	due	to	scanner	instability	or	RF	artifacts.
Global	Correlation	(GCORR)	‡
M	correlation	of	all	combinations	of	voxels	in	a	time	series.	Illustrates	differences	between	data	due	to	
motion/physiological	noise.	Larger	values	reflect	a	greater	degree	of	spatial	correlation	between	slices,	
which	may	be	due	to	head	motion	or	‘signal	leakage’	in	simultaneous	multi-slice	acquisitions.
Median	Distance	Index78	‡
M	distance	(1—spearman’s	rho)	between	each	time-point's	volume	and	the	median	volume	using	
AFNI’s	3dTqual 	command.	Higher	values	reflect	greater	differences	between	subsequent	frames,	which	
may	be	due	to	head	motion	or	technical	issues.
*	For	all	R-fMRI	data	temporal	metrics	have	been	computed	after	discarding	the	first	5	time	points	of	the	time	series	which	were	field	map	corrected	if	field	
†	For	R-fMRI	data	these	metrics	are	computed	on	mean	functional	data.
‡	For	R-fMRI	these	metrics	are	computed	on	time	series	data.	M,	Mean;	GM,	Gray	Matter;	WM,	White	Matter;	s.d.,	Standard	Deviation.
Adopted	from:	Di	Martino	A,	et	al.	2017.	Enhancing	studies	of	the	connectome	in	autism	using	the	autism	brain	imaging	data	exchange	II.	Sci	Data.	4:170010.	
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Figure 4. Median FD 
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Figure 5. QAP Measures 
 
a. Morphometry Quality Assessment
b. fMRI Quality Assessment
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Figure 6. Correlation between motion indices and phenotypic variables 
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Figure 7. EEG Channels 
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Figure 8. Age and Sex Distribution of HBN Participants 
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Figure 9. Diagnostic Breakdown of HBN Participants 
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